Sort

Search

Search Bar
26/12/2022 Diverse monogenic subforms of human spermatogenic failure
Nagirnaja, L, Lopes, AM, Charng, WL, Miller, B, Stakaitis, R, Golubickaite, I, Stendahl, A, Luan, TPC, Friedrich, C, Mahyari, E, Fadial, E, Kasak, L, Vigh-Conrad, K, Oud, MS, Xavier, MJ, Cheers, SR, James, ER, Guo, JT, Jenkins, TG, Riera-Escamilla, A, Barros, A, Carvalho, F, Fernandes, S, Goncalves, J, Gurnett, CA, Jorgensen, N, Jezek, D, Jungheim, ES, Kliesch, S, McLachlan, RI, Omurtag, KR, Pilatz, A, Sandlow, J, Smith, J, Eisenberg, ML, Hotaling, JM, Jarvi, KA, Punab, M, Rajpert-De Meyts, E, Carrell, DT, Krausz, C, Laan, M, O'Bryan, MK, Schlegel, PN, Tuttelmann, F, Veltman, JA, Almstrup, K, Aston, KI, Conrad, DF. Diverse monogenic subforms of human spermatogenic failure. Nature Communications. 2022; 13(1)DOI:10.1038/s41467-022-35661-z. PMID:36572685. IF:16.600(Q1/1D).
16/12/2022 Editorial: Genotype-phenotype correlations in neurodegenerative diseases: From clinical features to neuroimaging signatures
Ferraro, PM, Spotorno, N, Finegan, E, Sampedro, F, Caso, F. Editorial: Genotype-phenotype correlations in neurodegenerative diseases: From clinical features to neuroimaging signatures. Frontiers in Neurology. 2022; 13DOI:10.3389/fneur.2022.1100953. PMID:36588898. IF:3.400(Q2/5D).
16/12/2022 Secukinumab is effective and safe in the long-term treatment of plaque psoriasis in a daily practice setting: Multicenter study in 384 Spanish patients
Chicharro, P, Llamas-Velasco, M, Armesto, S, Acosta, EH, Vidal, D, Vilarrasa, E, Rivera-Diaz, R, De-la-Cueva, P, Martorell-Calatayud, A, Ballesca, F, Belinchon, I, Carretero, G, Rodriguez, L, Romero-Mate, A, Pujol-Montcusi, J, Salgado, L, Sahuquillo-Torralba, A, Coto-Segura, P, Rodriguez, OB, Feltes, R, Riera-Monroig, J, Dauden, E. Secukinumab is effective and safe in the long-term treatment of plaque psoriasis in a daily practice setting: Multicenter study in 384 Spanish patients. Dermatologic Therapy. 2022; 35(12)DOI:10.1111/dth.15929. PMID:36223184. IF:3.600(Q1/3D).
15/12/2022 Contribution of TEX15 genetic variants to the risk of developing severe non-obstructive oligozoospermia
Guzman-Jimenez, A, Gonzalez-Munoz, S, Cervan-Martin, M, Rivera-Egea, R, Garrido, N, Lujan, S, Santos-Ribeiro, S, Castilla, JA, Gonzalvo, MC, Clavero, A, Vicente, FJ, Maldonado, V, Villegas-Salmeron, J, Burgos, M, Jimenez, R, Pinto, MG, Pereira, I, Nunes, J, Sanchez-Curbelo, J, Lopez-Rodrigo, O, Pereira-Caetano, I, Marques, PI, Carvalho, F, Barros, A, Bassas, L, Seixas, S, Goncalves, J, Lopes, AM, Larriba, S, Palomino-Morales, RJ, Carmona, FD, Bossini-Castillo, L. Contribution of TEX15 genetic variants to the risk of developing severe non-obstructive oligozoospermia. Frontiers in Cell and Developmental Biology. 2022; 10DOI:10.3389/fcell.2022.1089782. PMID:36589743. IF:5.500(Q1/2D).